Michael E. Barish

1 ta ish

City Of Hope National Medical Center

1. Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma

   Christine E. Brown, Behnam Badie, Michael E. Barish +14

   MaqolaOAOchiq kirish20152 iqtibos

   ABIABI:AkademIndex/2026.other.020402